Publications database

This tool lets you examine and compare the penalties or rehabilitative responses for the core offences of drug use, possession for personal use, and supply-related offences, across countries in Europe. It also allows you to see how the laws vary those penalties according to the type or quantity of...

This report provides a comprehensive analysis of patterns emerging across Europe in the areas of drug supply, illicit drug use and associated public health problems. National data sets are also provided across these themes and on key harm-reduction interventions. The report is available in English...

Over the past quarter of a century, the EMCDDA has expanded its monitoring capability to keep pace with revolutionary changes in the extent and nature of the drugs problem and in the world in which we live. By complementing data routinely submitted by Member States with information from an...

COVID-19 is a major global health threat. People who use drugs face the same risks as those of the general population and therefore need to be aware of the appropriate advice to reduce their risk of infection. They can be exposed to additional risks, however, that require developing assessment and...

Country Drug Reports provide a top-level overview of the drug phenomenon in European countries, covering topics such as drug supply, drug use and public health problems as well as drug policy and responses. Each Country Drug Report focuses on a single country (28 EU Member States as well as Norway...

Country Drug Reports provide a top-level overview of the drug phenomenon in European countries, covering topics such as drug supply, drug use and public health problems as well as drug policy and responses. Each Country Drug Report focuses on a single country (28 EU Member States as well as Norway...

Commissioned each year by the EMCDDA and produced by the national focal points of the Reitox network, the National reports draw an overall picture of the drug phenomenon at national level in each EU Member state. These data are key information to the EMCDDA and are an important resource, among...

Summary: Commissioned each year by the EMCDDA and produced by the national focal points of the Reitox network, the National reports draw an overall picture of the drug phenomenon at national level in each EU Member state. These data are key information to the EMCDDA and are an important resource,...

Commissioned each year by the EMCDDA and produced by the national focal points of the Reitox network, the National reports draw an overall picture of the drug phenomenon at national level in each EU Member state. These data are key information to the EMCDDA and are an important resource, among...